SANA — Sana Biotechnology Share News
0.000.00%
Last trade - 00:00- $709.48m
- $548.99m
Pfizer, Flagship Pioneering to invest $100 mln in drug discovery (updated)
Pfizer, Flagship Pioneering to invest $100 mln for drug discovery
Live Markets: Digimarc among top 'squeeze' targets -S3 Partners
Brief: Sana Biotechnology Reports First Quarter 2023 Financial Results And Business Updates
Sana Biotechnology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sana Biotechnology Q1 net loss USD 82.123 million
Sana Biotechnology Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Sana Biotechnology Announces Preclinical Data Published Showing Ability Of Its Hypoimmune Allogeneic Cd19-Directed Car T Cells To Produce Durable Anti-Tumor Responses
Brief: Sana Biotechnology Says Goal To File IND For SC451 In 2024
Brief: Sana Biotechnology Reports Fourth Quarter And Full Year 2022 Financial Results
Sana Biotechnology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Sana Biotechnology Q4 adjusted net loss USD 77.193 million
Sana Biotechnology Inc expected to post a loss of 51 cents a share - Earnings Preview
Analysis: Biotech IPOs to bloom with spotlight on startups with human trial data
Brief: Sana Biotechnology Announces FDA Nod For Human Clinical Trials For Car T Therapy For B-Cell Malignancies
Brief: Sana Biotechnology Highlights Hypoimmune Allogeneic Car T Cell Programs And In Vivo Technology Platform
Sana down on halting heart muscle cell program, job cuts
Brief: Sana Biotechnology Confirms Key Program Timelines And Announces Portfolio Prioritization
Brief: Sana Biotechnology Reports Third Quarter 2022 Results